Access gaps widen for GLP-1 weight loss drugs despite rising demand
GLP-1 receptor agonists have become increasingly popular in the United States in recent years. Originally developed as treatments for type 2 diabetes, these drugs are now being used for weight management, cardiovascular health and other purposes. However, access to these medications is not equal across all populations.
Researchers at Boston University School of Public Health found that as GLP-1 use has grown, the gaps in who can access these drugs have actually gotten worse. According to their study, access disparities have expanded significantly, leaving some eligible patients unable to obtain these medications.
The findings underscore a growing concern: while demand for GLP-1 drugs continues to rise, many eligible patients face barriers to accessing them.
What it means in Raleigh
Behavioral health: Alliance Health (LME/MCO for Wake, Durham, Johnston, Orange, Cumberland, Mecklenburg)
Medicaid plans: NC Medicaid Standard Plans: AmeriHealth Caritas NC, Carolina Complete Health, Healthy Blue, UnitedHealthcare Community Plan, WellCare of NC. Tailored Plans: Alliance Health, Trillium Health Resources, Vaya Partners (Vaya Health + Partners Health Management, merged 2026).
Major insurers: Blue Cross NC, Aetna, Cigna, UnitedHealthcare, Humana
Plan lists change; confirm with your plan or the state agency.
